Clinical Trial Update: The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and potential impact of Huang-Lian-Jie-Du-Tang on survival in maintenance therapy for patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Huang-Lian-Jie-Du-Tang (Huanglian Jiedu Tang)

Snippet

Sponsor: Wuhan University | Conditions: Multiple Myeloma | Phase 1 | Status: UNKNOWN